HNGR Stock Overview
Hanger, Inc. provides orthotic and prosthetic (O&P) services in the United States.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$18.56|
|52 Week High||US$23.98|
|52 Week Low||US$13.42|
|1 Month Change||30.43%|
|3 Month Change||25.75%|
|1 Year Change||-16.73%|
|3 Year Change||-5.60%|
|5 Year Change||63.81%|
|Change since IPO||280.72%|
Recent News & Updates
|HNGR||US Healthcare||US Market|
Return vs Industry: HNGR underperformed the US Healthcare industry which returned 14.3% over the past year.
Return vs Market: HNGR underperformed the US Market which returned -13.5% over the past year.
|HNGR Average Weekly Movement||8.6%|
|Healthcare Industry Average Movement||8.9%|
|Market Average Movement||7.9%|
|10% most volatile stocks in US Market||17.0%|
|10% least volatile stocks in US Market||3.2%|
Stable Share Price: HNGR is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: HNGR's weekly volatility (9%) has been stable over the past year.
About the Company
Hanger, Inc. provides orthotic and prosthetic (O&P) services in the United States. It operates in two segments, Patient Care and Products & Services. The Patient Care segment owns and operates Hanger clinic, which specializes in the design, fabrication, and delivery of custom O&P devices through patient care clinics and satellite locations; and offers payor network contracting services to other O&P providers.
Hanger Fundamentals Summary
|HNGR fundamental statistics|
Is HNGR overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|HNGR income statement (TTM)|
|Cost of Revenue||US$796.67m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.95|
|Net Profit Margin||3.17%|
How did HNGR perform over the long term?See historical performance and comparison
Is HNGR undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 2/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for HNGR?
Other financial metrics that can be useful for relative valuation.
|What is HNGR's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does HNGR's PE Ratio compare to its peers?
|HNGR PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
NHC National HealthCare
TOI Oncology Institute
USPH U.S. Physical Therapy
PNTG Pennant Group
Price-To-Earnings vs Peers: HNGR is expensive based on its Price-To-Earnings Ratio (19.5x) compared to the peer average (-8.6x).
Price to Earnings Ratio vs Industry
How does HNGR's PE Ratio compare vs other companies in the US Healthcare Industry?
Price-To-Earnings vs Industry: HNGR is good value based on its Price-To-Earnings Ratio (19.5x) compared to the US Healthcare industry average (19.6x)
Price to Earnings Ratio vs Fair Ratio
What is HNGR's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||19.5x|
|Fair PE Ratio||25.6x|
Price-To-Earnings vs Fair Ratio: HNGR is good value based on its Price-To-Earnings Ratio (19.5x) compared to the estimated Fair Price-To-Earnings Ratio (25.6x).
Share Price vs Fair Value
What is the Fair Price of HNGR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: HNGR ($18.56) is trading above our estimate of fair value ($17.03)
Significantly Below Fair Value: HNGR is trading above our estimate of fair value.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
How is Hanger forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Future Growth Score2/6
Future Growth Score 2/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HNGR's forecast earnings growth (15.3% per year) is above the savings rate (1.9%).
Earnings vs Market: HNGR's earnings (15.3% per year) are forecast to grow faster than the US market (14.6% per year).
High Growth Earnings: HNGR's earnings are forecast to grow, but not significantly.
Revenue vs Market: HNGR's revenue (4.7% per year) is forecast to grow slower than the US market (7.9% per year).
High Growth Revenue: HNGR's revenue (4.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if HNGR's Return on Equity is forecast to be high in 3 years time
Discover growth companies
How has Hanger performed over the past 5 years?
Past Performance Score4/6
Past Performance Score 4/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: HNGR has high quality earnings.
Growing Profit Margin: HNGR's current net profit margins (3.2%) are higher than last year (2.8%).
Past Earnings Growth Analysis
Earnings Trend: HNGR has become profitable over the past 5 years, growing earnings by 73.5% per year.
Accelerating Growth: HNGR's earnings growth over the past year (25.5%) is below its 5-year average (73.5% per year).
Earnings vs Industry: HNGR earnings growth over the past year (25.5%) exceeded the Healthcare industry 10.9%.
Return on Equity
High ROE: Whilst HNGR's Return on Equity (29.78%) is high, this metric is skewed due to their high level of debt.
Discover strong past performing companies
How is Hanger's financial position?
Financial Health Score2/6
Financial Health Score 2/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: HNGR's short term assets ($282.9M) exceed its short term liabilities ($230.6M).
Long Term Liabilities: HNGR's short term assets ($282.9M) do not cover its long term liabilities ($611.1M).
Debt to Equity History and Analysis
Debt Level: HNGR's net debt to equity ratio (361.9%) is considered high.
Reducing Debt: HNGR's debt to equity ratio has reduced from 2453.5% to 381.4% over the past 5 years.
Debt Coverage: HNGR's debt is not well covered by operating cash flow (16%).
Interest Coverage: HNGR's interest payments on its debt are not well covered by EBIT (2.4x coverage).
Discover healthy companies
What is Hanger current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Cash Flow Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate HNGR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate HNGR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if HNGR's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if HNGR's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as HNGR has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Vinit Asar (56 yo)
Mr. Vinit K. Asar has been the Chief Executive Officer and President of Hanger Orthopedic Group Inc. (known as Hanger, Inc.) since May 21, 2012 and September 12, 2011 respectively. Mr. Asar serves as Direc...
CEO Compensation Analysis
Compensation vs Market: Vinit's total compensation ($USD4.61M) is about average for companies of similar size in the US market ($USD3.93M).
Compensation vs Earnings: Vinit's compensation has been consistent with company performance over the past year.
Experienced Management: HNGR's management team is seasoned and experienced (6.2 years average tenure).
Experienced Board: HNGR's board of directors are considered experienced (7.6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Hanger, Inc.'s employee growth, exchange listings and data sources
- Name: Hanger, Inc.
- Ticker: HNGR
- Exchange: NYSE
- Founded: 1861
- Industry: Health Care Facilities
- Sector: Healthcare
- Implied Market Cap: US$726.128m
- Shares outstanding: 39.12m
- Website: https://hangerclinic.com
Number of Employees
- Hanger, Inc.
- 10910 Domain Drive
- Suite 300
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/08/10 00:00|
|End of Day Share Price||2022/08/10 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.